Fidelity Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.06B Buy
24,771,828
+5,995,157
+32% +$1.4B 0.32% 42
2025
Q4
$3.89B Buy
18,776,671
+5,333,244
+40% +$1.05B 0.2% 70
2025
Q3
$2.49B Buy
13,443,427
+21,952
+0.2% +$3.76M 0.13% 124
2025
Q2
$2.05B Sell
13,421,475
-367,072
-3% -$56.4M 0.12% 141
2025
Q1
$2.29B Sell
13,788,547
-2,291,382
-14% -$359M 0.15% 113
2024
Q4
$2.33B Sell
16,079,929
-2,236,991
-12% -$347M 0.14% 113
2024
Q3
$2.97B Buy
18,316,920
+1,265,748
+7% +$202M 0.18% 83
2024
Q2
$2.49B Buy
17,051,172
+173,617
+1% +$25.8M 0.16% 94
2024
Q1
$2.67B Buy
16,877,555
+222,919
+1% +$35.5M 0.18% 82
2023
Q4
$2.61B Sell
16,654,636
-1,208,659
-7% -$185M 0.2% 76
2023
Q3
$2.78B Sell
17,863,295
-3,037,014
-15% -$501M 0.24% 62
2023
Q2
$3.46B Buy
20,900,309
+3,152,603
+18% +$509M 0.29% 52
2023
Q1
$2.75B Sell
17,747,706
-1,344,454
-7% -$217M 0.25% 65
2022
Q4
$3.37B Buy
19,092,160
+133,865
+0.7% +$23.1M 0.34% 51
2022
Q3
$3.1B Buy
18,958,295
+233,246
+1% +$39.5M 0.32% 47
2022
Q2
$3.32B Buy
18,725,049
+3,229,032
+21% +$575M 0.33% 44
2022
Q1
$2.75B Buy
15,496,017
+3,087,877
+25% +$525M 0.22% 71
2021
Q4
$2.12B Sell
12,408,140
-484,712
-4% -$79.4M 0.16% 103
2021
Q3
$2.08B Sell
12,892,852
-422,023
-3% -$72M 0.17% 99
2021
Q2
$2.19B Buy
13,314,875
+270,343
+2% +$44.8M 0.17% 95
2021
Q1
$2.14B Sell
13,044,532
-793,891
-6% -$128M 0.18% 97
2020
Q4
$2.18B Sell
13,838,423
-1,377,735
-9% -$203M 0.19% 88
2020
Q3
$2.27B Sell
15,216,158
-821,602
-5% -$122M 0.23% 78
2020
Q2
$2.26B Sell
16,037,760
-1,105,456
-6% -$161M 0.25% 69
2020
Q1
$2.25B Sell
17,143,216
-802,550
-4% -$114M 0.31% 56
2019
Q4
$2.62B Buy
17,945,766
+799,194
+5% +$108M 0.29% 61
2019
Q3
$2.22B Buy
17,146,572
+1,125,459
+7% +$148M 0.27% 67
2019
Q2
$2.23B Sell
16,021,113
-1,821,637
-10% -$252M 0.26% 66
2019
Q1
$2.49B Sell
17,842,750
-2,524,295
-12% -$338M 0.3% 58
2018
Q4
$2.63B Sell
20,367,045
-540,935
-3% -$75.5M 0.36% 42
2018
Q3
$2.89B Buy
20,907,980
+1,508,727
+8% +$200M 0.33% 47
2018
Q2
$2.35B Sell
19,399,253
-1,099,543
-5% -$137M 0.27% 58
2018
Q1
$2.63B Sell
20,498,796
-4,032,620
-16% -$545M 0.31% 48
2017
Q4
$3.43B Sell
24,531,416
-935,286
-4% -$130M 0.4% 35
2017
Q3
$3.31B Sell
25,466,702
-1,770,946
-7% -$235M 0.4% 34
2017
Q2
$3.6B Buy
27,237,648
+1,509,745
+6% +$193M 0.45% 30
2017
Q1
$3.2B Sell
25,727,903
-7,117,440
-22% -$850M 0.41% 38
2016
Q4
$3.78B Sell
32,845,343
-5,117,644
-13% -$591M 0.51% 27
2016
Q3
$4.48B Sell
37,962,987
-5,472,095
-13% -$664M 0.6% 21
2016
Q2
$5.27B Sell
43,435,082
-8,656,507
-17% -$984M 0.72% 14
2016
Q1
$5.64B Sell
52,091,589
-1,331,482
-2% -$138M 0.78% 15
2015
Q4
$5.49B Buy
53,423,071
+2,022,480
+4% +$203M 0.74% 18
2015
Q3
$4.8B Sell
51,400,591
-933,608
-2% -$90.3M 0.68% 20
2015
Q2
$5.1B Sell
52,334,199
-9,100,250
-15% -$911M 0.65% 21
2015
Q1
$6.18B Sell
61,434,449
-483,433
-0.8% -$49.2M 0.79% 14
2014
Q4
$6.47B Buy
61,917,882
+8,730,671
+16% +$920M 0.84% 12
2014
Q3
$5.67B Buy
53,187,211
+972,150
+2% +$101M 0.77% 10
2014
Q2
$5.46B Buy
52,215,061
+7,959,278
+18% +$804M 0.73% 12
2014
Q1
$4.35B Buy
44,255,783
+10,634,944
+32% +$986M 0.6% 23
2013
Q4
$3.08B Buy
33,620,839
+4,571,692
+16% +$421M 0.44% 36
2013
Q3
$2.52B Sell
29,049,147
-6,116,533
-17% -$549M 0.39% 47
2013
Q2
$3.02B Buy
+35,165,680
New +$2.98B 0.49% 32

Other funds holding JNJ

Fidelity Investments's JNJ Position: Q1 2026 in Review

Fidelity Investments increased its Johnson & Johnson (JNJ) stake by 32% in Q1 2026, buying an estimated $1.4B and bringing the position to 24,771,828 shares worth $6.06B. The position accounts for 0.32% of the portfolio, ranked #42.

Fidelity Investments first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.47B in Q4 2014. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Fidelity Investments held 24,771,828 shares of Johnson & Johnson worth $6.06B as of Q1 2026.
  • Fidelity Investments bought 5,995,157 Johnson & Johnson shares in Q1 2026, an estimated $1.4B.
  • Johnson & Johnson made up 0.32% of Fidelity Investments's portfolio in Q1 2026, its #42 holding.
  • Fidelity Investments first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Fidelity Investments's Johnson & Johnson position peaked at $6.47B in Q4 2014.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.